Addition of IGF-II promotes a profibrotic environment and further exacerbates the profibrotic state of IPF and SSc both intracellularly and extracellularly, significantly and drastically altering the fibrotic milieu, thus favoring an environment of ECM accumulation and/or reduced ECM degradation. This evidence concerns the gene IGF2 and systemic sclerosis.